How Chris Shaffer Turned A Near-Fatal Superinfection Into A National Phage Therapy Mission

Chris Shaffer did not set out to become a public voice in health care. He was a longtime educator fighting to stay alive after a drug-resistant E. coli superinfection kept returning while antibiotics failed to clear it. Phage therapy, which uses viruses that attack bacteria, finally wiped out the infection after months of care and gave him a second life. The book he later wrote turned that escape into a warning for the country and a message for patients who may be running out of options.

When Medicine Ran Out of Road

Shaffer’s story lands hard because the danger was real from the start. He writes of a stretch marked by loneliness, confusion, and fear, with nights spent swinging between hope and dread. Repeated rounds of antibiotics brought side effects and brief relief, then the same infection came back again. Tests showed an antimicrobial-resistant E. coli infection with ESBL, and the normal medical playbook kept circling the same drugs even after those drugs kept failing.

Western medicine, in his account, had little to offer beyond stronger pills, harsher infusions, and more waiting. Faced with a body growing weaker and a system with few new answers, he threw himself into research. That search led him toward phage therapy, a field almost no one around him seemed ready to explain.

Doctors did not hand him a clear path. Many told him they knew little about phage therapy, and some warned him away because it was still viewed as experimental in the United States. Fear did not stop him. He read case studies, learned unfamiliar science, and kept chasing the word “phage” until it stopped sounding remote and started sounding like a lifeline.

Bacteriophages are viruses that target bacteria rather than human cells, and that idea slowly moved from strange theory to serious hope in his mind. He came to believe he might have to teach his own physicians what he was learning simply to keep the discussion alive. In the pages of his book, that stubbornness becomes a kind of quiet fire. “A way forward exists. I found it. And so can you.”

The Long Road to the Cure

Nothing about Shaffer’s path feels polished. He was shipping samples, reading lab reports, emailing people overseas, and making hard choices while sick and exhausted. American routes to phage therapy looked painfully slow to him, with compassionate use seen as a last move and other channels tied up in delays he felt he could not survive.

Tbilisi, Georgia, became the turning point. Shaffer chose the Eliava Phage Therapy Center because it could test his bacteria, build a custom phage, and track his treatment in one place. He believed that close watch mattered because custom phage work takes more than a lucky guess. He flew there in June 2023 weak enough that his niece went with him in case he became too ill to manage the trip alone.

Treatment did not arrive like a movie miracle. Shaffer took phage in rounds, stayed under careful watch, and kept following lab results while doctors adjusted his care. His first round was stretched because he was so ill, and he kept going through more cycles and pauses while waiting for firm proof that the therapy was biting into the infection.

Then the numbers started to move. After antibiotics had failed to push down his colony counts, phage began to cut them, first to under 25,000 and then to under 10,000. During that period, he traveled to a phage conference in Washington and listened to scientists discuss the same kind of drop he was starting to see in his own body. Science and lived experience, which had seemed far apart, suddenly met in the same room.

One morning during the last round, he looked in the mirror and felt something had changed before any lab report arrived. He believed the infection had finally lost its grip. Later tests supported that feeling, and he writes that he has remained free of E. coli since then. “Phage did in four months what antibiotics failed to do in over two years.”

A Mission Bigger Than One Patient

Survival gave Shaffer more than relief. It gave him a cause. His book argues that many physicians in the United States still receive little exposure to phage therapy even while major research centers such as Yale, UC San Diego, Texas A&M, the Mayo Clinic, and the U.S. Navy study phages and maintain major libraries of them. That gap, to him, is no small oversight.

He wants phage therapy taught more widely, discussed more openly, and made easier to reach for people facing resistant infections. He presses for laws that would open a faster path to custom phage work before patients run through every antibiotic left on the shelf. His argument carries weight because it rises from lived pain rather than theory. Long nights, failed drugs, and the threat of collapse sit behind every page.

That urgency now feeds the work around Phage One Voice, the nonprofit he leads. He has said he wants the public to hear his story and wants suffering patients to learn that options may exist beyond antibiotics alone. He has secured access to a large phage library through that wider mission, a sign that he is thinking past one rescue and toward a larger public fight.

Health stories often stay locked inside hospitals, charts, and private fear. Shaffer refuses to let his story stay there. He does not cast phage therapy as magic, and his own writing leaves room for physician guidance, caution, and more study. Still, his story leaves behind a sharp truth: when antibiotics fail, hope should not have to cross an ocean in silence.